Barinthus Biotherapeutics BRNS
BRNS
$0.74 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Barinthus Biotherapeutics (BRNS) Other Non-Current Assets (2021 - 2026)

Updated

Barinthus Biotherapeutics (BRNS) reported Other Non-Current Assets of $919,000 for Q2 2026, down 2.6% from $944,000 a year earlier but up 0.5% from the prior quarter.

Analysis

Barinthus Biotherapeutics (BRNS) Other Non-Current Assets (2021 - 2026) Analysis & Trends

At the end of FY2025, Barinthus Biotherapeutics posted Other Non-Current Assets of $930,000, up 5.6% from FY2024.

  • Other Non-Current Assets has a four-year compound annual growth rate of 3.7% (FY2021 to FY2025).
  • By year, Other Non-Current Assets came in at $881,000 in FY2024 (-0.1%), $882,000 in FY2023 (-9.6%), $976,000 in FY2022 (+21.4%) and $804,000 in FY2021.
  • Five-year quarterly Other Non-Current Assets spans a low of $719,000 in Q3 2021 and a high of $1.06 million in Q3 2023.
  • Year over year, Other Non-Current Assets gained in five of the last eight quarters, with growth averaging 0.1%.
  • The high point for year-over-year Other Non-Current Assets in five years was Q1 2023 (growth of 30.5%); the low point was Q1 2022 (a decline of 51.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $914,000 (Q1 2026), $930,000 (Q4 2025) and $929,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Barinthus Biotherapeutics 30.23 Mn 30.29 Mn - 919,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 919,000.00
Mar 31, 2026 914,000.00
Dec 31, 2025 930,000.00
Sep 30, 2025 929,000.00
Jun 30, 2025 944,000.00
Mar 31, 2025 902,000.00
Dec 31, 2024 881,000.00
Sep 30, 2024 926,000.00
Jun 30, 2024 886,000.00
Mar 31, 2024 885,000.00
Dec 31, 2023 882,000.00
Sep 30, 2023 1.06 Mn
Jun 30, 2023 1.01 Mn
Mar 31, 2023 1.03 Mn
Dec 31, 2022 976,000.00
Sep 30, 2022 847,000.00
Jun 30, 2022 902,000.00
Mar 31, 2022 788,000.00
Dec 31, 2021 804,000.00
Sep 30, 2021 719,000.00
API Access

Barinthus Biotherapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=BRNS&period=max&api_key=YOUR_API_KEY